Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Alginates × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Trastuzumab 539 Paclitaxel 498 Cyclophosphamide 479 Docetaxel 422 Capecitabine 366 Letrozole 321 Fulvestrant 282 Doxorubicin 256 Tamoxifen 239 Carboplatin 236 Anastrozole 203 Radiotherapy 199 exemestane 192 Epirubicin 176 Bevacizumab 168 palbociclib 160 Lapatinib 153 Vinorelbine 149 pertuzumab 148 Gemcitabine 145 pembrolizumab 143 Surveys and Questionnaires 121 Exercise 117 Magnetic Resonance Spectroscopy 113 eribulin 106 Fluorouracil 104 Albumin-Bound Paclitaxel 104 Blood Specimen Collection 99 130-nm albumin-bound paclitaxel 95 Everolimus 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡